Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Viswanathan Ravi
Relationship:   10% Owner
City:   Timonium
State:   MD
   
Insider Summary:
  
   
Companies Owned :   30    
Direct Shares   5,490,582    

Indirect Shares

   180,638,890      
Direct Value   $257,830,121    

Indirect Value

   $813,051,860      
Total Shares   186,129,472      
Total Value   $1,070,881,982      


Ra Pharmaceuticals, Inc. $257,813,828 Appian Corp $16,293 Ra Pharmaceuticals, Inc. $257,813,828 Appian Corp $16,293
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clovis Oncology, Inc. CLVS 10% Owner 2011-11-21 0 2013-06-03 383    Premium*  
            Millennial Media Inc MM 10% Owner 2012-04-03 0 2012-10-29 8,196,614    Premium*  
            Tesaro, Inc. TSRO 10% Owner 2012-07-03 0 2018-03-06 739,516    Premium*  
            Workday, Inc. WDAY 10% Owner 2013-04-09 0 2013-04-09 781    Premium*  
            Interleukin Genetics Inc ILIU 10% Owner 0 2016-07-29 55,418,811    Premium*  
            Epizyme, Inc. EPZM 10% Owner 2013-06-05 0 2016-01-12 6,260,851    Premium*  
            Care.com Inc CRCM 10% Owner 2014-01-29 0 2017-11-06 336    Premium*  
            Roka Bioscience, Inc. ROKA 10% Owner 0 2014-07-22 3,216,810    Premium*  
            Loxo Oncology, Inc. LOXO 10% Owner 2014-08-06 0 2014-08-06 1,789,420    Premium*  
            Box Inc BOX 10% Owner 0 2015-01-28 0    Premium*  
            Tracon Pharmaceuticals, Inc. TCON 10% Owner 2015-02-04 0 2016-11-29 2,758,039    Premium*  
            Champions Biotechnology Inc CSBR 10% Owner 0 2015-03-11 18,750,000    Premium*  
            Ardelyx Inc ARDX 10% Owner 0 2018-05-25 3,082,186    Premium*  
            Nuvelo Inc ABIO 10% Owner 0 2018-02-26 0    Premium*  
            Synlogic Inc SYBX 10% Owner 2015-10-05 0 2018-01-26 4,228,940    Premium*  
            Avalo Therapeutics, Inc AVTX 10% Owner 2015-10-20 0 2015-10-20 594,245    Premium*  
            Adaptimmune Therapeutics PLC ADAP 10% Owner 0 2018-09-07 12,000,000    Premium*  
            Aveo Pharmaceuticals Inc AVEO 10% Owner 0 2018-08-21 18,698,038    Premium*  
            Achaogen Inc AKAO 10% Owner 0 2016-12-19 5,215,128    Premium*  
            Ra Pharmaceuticals, Inc. RARX 10% Owner 2018-02-16 5,490,073 2016-10-31 3,490,073    Premium*  
            Cascadian Therapeutics, Inc CASC 10% Owner 0 2018-03-09 0    Premium*  
            Mulesoft, Inc MULE 10% Owner 0 2018-05-01 0    Premium*  
            Mersana Therapeutics, Inc. MRSN 10% Owner 2017-07-03 0 2017-07-03 8,140,138    Premium*  
            Regulus Therapeutics Inc. RGLS 10% Owner 0 2017-07-24 10,989,010    Premium*  
            Surface Oncology, Inc. SURF 10% Owner 2018-04-23 0 2018-04-23 3,312,877    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM 10% Owner 2017-10-10 0 2017-10-10 4,909,956    Premium*  
            Appian Corp APPN 10% Owner 2018-02-13 509 2018-02-13 1,014    Premium*  
            Elastic N.v. ESTC 10% Owner 2018-10-10 0 2018-10-10 2,197,503    Premium*  
            Phasebio Pharmaceuticals Inc PHAS 10% Owner 2018-10-22 0 2018-10-22 6,641,634    Premium*  
            Duolingo, Inc. DUOL 10% Owner 2022-02-15 0 2022-07-08 6,587    Premium*  
* Premium Members only  

Records found :    124         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
EPZM Epizyme, Inc. 10% Owner   –       –       •   2016-01-12 4 B $9.00 $9,999,999 I/I 1,111,111 5,854,351 1.5 -
ARDX Ardelyx Inc 10% Owner   –       –       •   2016-01-13 4 B $10.00 $10,000,000 I/I 1,000,000 1,901,869 1.5 -
TSRO Tesaro, Inc. 10% Owner   –       –       •   2016-03-18 4 B $35.19 $49,999,993 I/I 1,420,858 710,429 1.5 -
ARDX Ardelyx Inc 10% Owner   –       –       •   2016-07-18 4 B $8.73 $13,333,338 I/I 1,527,301 2,665,519 1.5 -
ILIU Interleukin Genetics Inc 10% Owner   –       –       •   2016-07-29 4 B $0.10 $2,000,000 I/I 20,120,724 55,418,811 1.5 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2016-10-31 4 B $13.00 $4,400,006 I/I 338,462 3,490,073 1.5 -
TCON Tracon Pharmaceuticals, I... 10% Owner   –       –       •   2016-11-29 4 B $5.75 $4,999,999 I/I 869,565 2,758,039 1.5 -
AKAO Achaogen Inc 10% Owner   –       –       •   2016-12-19 4 B $13.50 $6,750,000 I/I 500,000 5,215,128 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2017-03-27 4 B $0.70 $9,009,000 I/I 12,870,000 72,139,000 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2017-03-28 4 B $0.50 $3,000,000 I/I 6,000,000 16,362,694 1.5 -
MRSN Mersana Therapeutics, Inc... 10% Owner   –       –       •   2017-07-03 4 B $15.00 $15,000,000 I/I 1,000,000 8,140,138 1.5 -
RYTM Rhythm Pharmaceuticals, I... 10% Owner   –       –       •   2017-10-10 4 B $17.00 $9,350,000 I/I 550,000 4,909,956 1.5 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2018-02-16 4 B $6.00 $12,000,000 D/D 2,000,000 5,490,073 2.45 -
TSRO Tesaro, Inc. 10% Owner   –       –       •   2018-03-02 4 B $54.32 $3,795,185 I/I 68,302 724,089 1.5 -
TSRO Tesaro, Inc. 10% Owner   –       –       •   2018-03-05 4 B $58.28 $3,614,335 I/I 61,437 736,357 1.5 -
TSRO Tesaro, Inc. 10% Owner   –       –       •   2018-03-06 4 B $59.82 $944,665 I/I 15,793 739,516 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-21 4 B $1.81 $189,820 I/I 104,844 72,243,844 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-22 4 B $1.90 $1,655,669 I/I 869,574 73,113,418 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-23 4 B $1.95 $572,358 I/I 294,090 73,407,508 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-26 4 B $1.90 $1,087,553 I/I 571,164 73,978,672 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-27 4 B $1.92 $11,500,200 I/I 6,000,000 79,978,672 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-04-06 4 B $2.24 $1,536,943 I/I 685,676 17,048,370 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-04-09 4 B $2.43 $78,099 I/I 32,100 17,080,470 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-04-10 4 B $2.46 $499,994 I/I 203,200 17,283,670 1.5 -
SURF Surface Oncology, Inc. 10% Owner   –       –       •   2018-04-23 4 B $15.00 $1,999,995 I/I 133,333 3,312,877 1.5 -
  124  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us